The bear phase in Regeneron (REGN) appears over. Shares bottomed at around $550 - $575 and jumped by around 12% to over $650 on Tuesday. The firm reported revenue increasing by 0.8% to $3.75 billion.
Regeneron posted strong sales of Dupixent, at $4.9 billion. This more than offset the weak sales from EYLEA. Still, EYLEA HD sales grew by 42%, to $663 million. To manage costs, the firm lowered its R&D and SG&A expense forecast for the fiscal year.
UPS, although down nearly 25% in 2025, added 8.0% after it posted results. UPS posted non-GAAP EPS of $1.74 on revenue of $21.4 billion (-3.6% Y/Y). Stock markets rallied after the firm announced a massive 48,000 job cut. Unfortunately, staff in the operational unit will face 34,000 job cuts. UPS will cut 14,000 roles at the management level.
Zebra (ZBRA) continued to break down on stock markets. The downtrend began in August and accelerated on Oct. 28. ZBRA stock lost 11.68% after it posted Q3 revenue of $4.8 billion. Despite posting a free cash flow of over $800 million and non-GAAP EPS exceeding estimates for Q4, shares fell.
In the afternoon, the Federal Reserve will announce a widely anticipated rate cut. Expect bond markets to respond positively. Banks might dip after their recent bounce back on profit-taking. Watch Wells Fargo (WFC), Bank of America (BAC), and JPMorgan Chase (JPM).
Related Stories
